NCT05212298

Brief Summary

This project is planned to collect non-dialysis adults who suffer from sleep and tinnitus disorders and refuse to take sleeping medicines in our hospital by random assignment and double-blind method. 120 adults were divided into 3 groups.

  1. 1.Control group: receive placebo treatment, once a day, four pills each time.
  2. 2.Herbal compound low-dose group: once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 582 mg.
  3. 3.Herbal compound high-dose group: once a day, four capsules each time. The total amount of herbal compound capsules is 1164 mg.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2021

Completed
20 days until next milestone

Study Start

First participant enrolled

September 16, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 28, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

4.4 years

First QC Date

August 27, 2021

Last Update Submit

February 2, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pittsburgh Sleep Quality Index

    The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each aspect has a minimum score of 0 and a maximum of 3 points. The total score range is 0-21 points. When the PSQI score is greater than 5 points, it indicates that there is a sleep quality disorder. The higher the score, the worse the sleep quality.

    3 month

  • Tinnitus Handicap Inventory

    The Tinnitus Handicap Inventory (THI) comprises 25 items grouped into three subscales: Functional, Emotional, and Catastrophic. The Functional subscale (11 items) deals with limitations caused by tinnitus in the areas of mental, social, and physical functioning. The Emotional subscale (9 items) concerns affective responses to tinnitus, e.g. anger, frustration, depression, anxiety. The Catastrophic subscale (5 items) probes the most severe reactions to tinnitus, such as loss of control, inability to escape from tinnitus, and fear of having a terrible disease. For each item a patient can respond with a "yes" (scored 4 points), "sometimes" (2 points), or "no" (0 points). The responses are summed within each subscale and for the total scale. The higher the score, the greater the perceived tinnitus severity.

    3 month

Study Arms (3)

Control

PLACEBO COMPARATOR

receive placebo treatment, once a day, four pills each time.

Dietary Supplement: The gel contains a mixture of glucose and maltodextrin

Herbal compound low-dose

EXPERIMENTAL

once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 582 mg.

Dietary Supplement: Herbal compound low-dose

Herbal compound high-dose

EXPERIMENTAL

once a day, four capsules each time. The total amount of herbal compound capsules is 1164 mg.

Dietary Supplement: Herbal compound high-dose

Interventions

The gel contains a mixture of glucose and maltodextrin - a complex carbohydrate - along with fat and a trace of protein.

Control
Herbal compound low-doseDIETARY_SUPPLEMENT

The total amount of herbal compound capsules is 582 mg.

Herbal compound low-dose
Herbal compound high-doseDIETARY_SUPPLEMENT

The total amount of herbal compound capsules is 1164 mg.

Herbal compound high-dose

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20\~70 years old
  • Non-dialysis patients
  • Suffering from sleep disorders and tinnitus
  • Refuse to take sleeping pills

You may not qualify if:

  • Patients who are bedridden or unable to take care of themselves.
  • dialysis patients.
  • Patients who cannot understand the details of this study or cannot cooperate with the examination.
  • History of alcohol or drug abuse.
  • Pregnant and lactating women
  • Patients with moderate to severe sleep apnea
  • Take sleeping pills

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Chiayi City, 66247, Taiwan

Location

MeSH Terms

Conditions

ParasomniasTinnitus

Interventions

maltodextrin

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Juen-Haur Hwang, MD, PhD.

    Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2021

First Posted

January 28, 2022

Study Start

September 16, 2021

Primary Completion

January 31, 2026

Study Completion

January 31, 2026

Last Updated

February 4, 2026

Record last verified: 2026-02

Locations